Ignite Creation Date:
2025-12-25 @ 3:54 AM
Ignite Modification Date:
2026-03-11 @ 6:51 AM
Study NCT ID:
NCT03925402
Status:
COMPLETED
Last Update Posted:
2023-03-29
First Post:
2019-04-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ertapenem for Initial Empirical Treatment of Third Generation Cephalosporin Resistant Enterobacteriaceae Bacteremia
Sponsor:
Phramongkutklao College of Medicine and Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AMED2019
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None